527 related articles for article (PubMed ID: 21867818)
1. The impact of guidelines on the outcomes of community-acquired and ventilator-associated pneumonia.
Ferrer M; Menendez R; Amaro R; Torres A
Clin Chest Med; 2011 Sep; 32(3):491-505. PubMed ID: 21867818
[TBL] [Abstract][Full Text] [Related]
2. Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.
Frei CR; Attridge RT; Mortensen EM; Restrepo MI; Yu Y; Oramasionwu CU; Ruiz JL; Burgess DS
Clin Ther; 2010 Feb; 32(2):293-9. PubMed ID: 20206787
[TBL] [Abstract][Full Text] [Related]
3. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia.
Torres A; Ferrer M; Badia JR
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S48-53. PubMed ID: 20597672
[TBL] [Abstract][Full Text] [Related]
4. Antibiotic therapy for community-acquired pneumonia with septic shock: follow the guidelines.
Blot S; Depuydt P
Crit Care Med; 2007 Jun; 35(6):1617-8. PubMed ID: 17522537
[No Abstract] [Full Text] [Related]
5. Improvement of process-of-care and outcomes after implementing a guideline for the management of community-acquired pneumonia: a controlled before-and-after design study.
Capelastegui A; España PP; Quintana JM; Gorordo I; Ortega M; Idoiaga I; Bilbao A
Clin Infect Dis; 2004 Oct; 39(7):955-63. PubMed ID: 15472846
[TBL] [Abstract][Full Text] [Related]
6. Community acquired bacterial pneumonia.
Anevlavis S; Bouros D
Expert Opin Pharmacother; 2010 Feb; 11(3):361-74. PubMed ID: 20085502
[TBL] [Abstract][Full Text] [Related]
7. Drugs of choice for community-acquired bacterial pneumonia.
Med Lett Drugs Ther; 2007 Jul; 49(1266):62-4. PubMed ID: 17652999
[No Abstract] [Full Text] [Related]
8. [The Japanese Respiratory Society guidelines for management of community-acquired pneumonia in adults].
Matsushima T;
Nihon Rinsho; 2003 Feb; 61 Suppl 2():677-81. PubMed ID: 12722300
[No Abstract] [Full Text] [Related]
9. Impact of guidelines on outcome: the evidence.
Martínez R; Reyes S; Lorenzo MJ; Menéndez R
Semin Respir Crit Care Med; 2009 Apr; 30(2):172-8. PubMed ID: 19296417
[TBL] [Abstract][Full Text] [Related]
10. New guidelines for the management of adult community-acquired pneumonia.
Armitage K; Woodhead M
Curr Opin Infect Dis; 2007 Apr; 20(2):170-6. PubMed ID: 17496576
[TBL] [Abstract][Full Text] [Related]
11. Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.
Grenier C; Pépin J; Nault V; Howson J; Fournier X; Poirier MS; Cabana J; Craig C; Beaudoin M; Valiquette L
J Antimicrob Chemother; 2011 Jul; 66(7):1617-24. PubMed ID: 21586592
[TBL] [Abstract][Full Text] [Related]
12. The halo effect of adherence to guidelines extends to patients with severe community-acquired pneumonia requiring admission to an intensive care unit.
Marrie TJ
Clin Infect Dis; 2005 Dec; 41(12):1717-9. PubMed ID: 16288393
[No Abstract] [Full Text] [Related]
13. Do guidelines change outcomes in ventilator-associated pneumonia?
Bassi GL; Ferrer M; Saucedo LM; Torres A
Curr Opin Infect Dis; 2010 Apr; 23(2):171-7. PubMed ID: 20134322
[TBL] [Abstract][Full Text] [Related]
14. [Management of adult patients with community-acquired pneumonia. Evidence-based guidelines from the Swedish Infectious Diseases Association].
Strålin K; Goscinski G; Hedlund J; Lidman C; Spindler C; Ortqvist A; Holmberg H
Lakartidningen; 2008 Sep 17-23; 105(38):2582-7. PubMed ID: 18846863
[No Abstract] [Full Text] [Related]
15. Challenges in the design and conduct of clinical trials for hospital-acquired pneumonia and ventilator-associated pneumonia: an industry perspective.
Barriere SL
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S4-9. PubMed ID: 20597670
[TBL] [Abstract][Full Text] [Related]
16. Empiric treatment in hospitalized community-acquired pneumonia. Impact on mortality, length of stay and re-admission.
Reyes Calzada S; Martínez Tomas R; Cremades Romero MJ; Martínez Moragón E; Soler Cataluña JJ; Menéndez Villanueva R
Respir Med; 2007 Sep; 101(9):1909-15. PubMed ID: 17628462
[TBL] [Abstract][Full Text] [Related]
17. Fluoroquinolones in the management of community-acquired pneumonia.
Albertson TE; Dean NC; El Solh AA; Gotfried MH; Kaplan C; Niederman MS
Int J Clin Pract; 2010 Feb; 64(3):378-88. PubMed ID: 20456176
[TBL] [Abstract][Full Text] [Related]
18. [Preventive measures for drug resistant bacteria by guidelines].
Tomono K
Nihon Rinsho; 2007 Feb; 65 Suppl 2 Pt. 1():531-3. PubMed ID: 17455675
[No Abstract] [Full Text] [Related]
19. Recommendations for treatment of hospital-acquired and ventilator-associated pneumonia: review of recent international guidelines.
File TM
Clin Infect Dis; 2010 Aug; 51 Suppl 1():S42-7. PubMed ID: 20597671
[TBL] [Abstract][Full Text] [Related]
20. Timely antibiotic therapy for community-acquired pneumonia.
Mansel JK
J Miss State Med Assoc; 2004 May; 45(5):159. PubMed ID: 15162706
[No Abstract] [Full Text] [Related]
[Next] [New Search]